Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers.

Nevler A, Muller AJ, Sutanto-Ward E, DuHadaway JB, Nagatomo K, Londin E, O'Hayer K, Cozzitorto JA, Lavu H, Yeo TP, Curtis M, Villatoro T, Leiby BE, Mandik-Nayak L, Winter JM, Yeo CJ, Prendergast GC, Brody JR.

Clin Cancer Res. 2019 Jan 15;25(2):724-734. doi: 10.1158/1078-0432.CCR-18-0814. Epub 2018 Sep 28.

PMID:
30266763
2.

IDO1 is an Integral Mediator of Inflammatory Neovascularization.

Mondal A, Smith C, DuHadaway JB, Sutanto-Ward E, Prendergast GC, Bravo-Nuevo A, Muller AJ.

EBioMedicine. 2016 Dec;14:74-82. doi: 10.1016/j.ebiom.2016.11.013. Epub 2016 Nov 9.

3.

IDO is a nodal pathogenic driver of lung cancer and metastasis development.

Smith C, Chang MY, Parker KH, Beury DW, DuHadaway JB, Flick HE, Boulden J, Sutanto-Ward E, Soler AP, Laury-Kleintop LD, Mandik-Nayak L, Metz R, Ostrand-Rosenberg S, Prendergast GC, Muller AJ.

Cancer Discov. 2012 Aug;2(8):722-35. doi: 10.1158/2159-8290.CD-12-0014. Epub 2012 Jul 19.

4.

Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.

Muller AJ, DuHadaway JB, Chang MY, Ramalingam A, Sutanto-Ward E, Boulden J, Soler AP, Mandik-Nayak L, Gilmour SK, Prendergast GC.

Cancer Immunol Immunother. 2010 Nov;59(11):1655-63. doi: 10.1007/s00262-010-0891-4. Epub 2010 Jul 17.

5.

Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.

Ramalingam A, Duhadaway JB, Sutanto-Ward E, Wang Y, Dinchuk J, Huang M, Donover PS, Boulden J, McNally LM, Soler AP, Muller AJ, Duncan MK, Prendergast GC.

Cancer Res. 2008 Mar 15;68(6):1683-90. doi: 10.1158/0008-5472.CAN-07-6072.

6.

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.

Banerjee T, Duhadaway JB, Gaspari P, Sutanto-Ward E, Munn DH, Mellor AL, Malachowski WP, Prendergast GC, Muller AJ.

Oncogene. 2008 May 1;27(20):2851-7. Epub 2007 Nov 19.

PMID:
18026137
7.

Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression.

Chang MY, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, Muller AJ, Prendergast GC.

Cancer Res. 2007 Jan 1;67(1):100-7.

8.

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC.

Nat Med. 2005 Mar;11(3):312-9. Epub 2005 Feb 13.

PMID:
15711557
9.

Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts.

Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC.

Cancer Biol Ther. 2004 Dec;3(12):1236-42. Epub 2004 Dec 14.

PMID:
15611650
10.

Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats.

Watson JC, Sutanto-Ward E, Osaku M, Weinstein JK, Babb JS, Sigurdson ER.

Surgery. 1999 Aug;126(2):358-63.

PMID:
10455906
11.

Regional chemotherapy for colorectal hepatic metastases: evidence for improved survival with new drug combinations.

Sutanto-Ward E, Arisawa Y, Tremiterra S, Sigurdson ER.

Ann Surg Oncol. 1996 Jan;3(1):36-43.

PMID:
8770300
12.

Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy.

Arisawa Y, Sutanto-Ward E, Fortunato L, Sigurdson ER.

Ann Surg Oncol. 1995 Mar;2(2):114-20.

PMID:
7537164
13.

Short-term intrahepatic FUdR infusion combined with bolus mitomycin C: reduced risk for developing drug resistance.

Arisawa Y, Sutanto-Ward E, Dalton RR, Sigurdson ER.

J Surg Oncol. 1994 Jun;56(2):75-80.

PMID:
8007682
14.

Localization of complement-fixing cytotoxic monoclonal antibodies to subcutaneous tumors and liver metastases in a syngeneic immunocompetent rat colon carcinoma model.

O'Boyle KP, Mattes MJ, Sigurdson ER, Sutanto-Ward E, Divgi CR, Welt S, Wright KE.

J Immunother Emphasis Tumor Immunol. 1994 Apr;15(3):175-84.

PMID:
8032540
15.

Quantitation of total metastatic tumor volume in the rat liver: correlation of MR and histologic measurements.

Mahmood U, Devitt ML, Kocheril PG, Sutanto-Ward E, Ballon D, Sigurdson ER, Koutcher JA.

J Magn Reson Imaging. 1992 May-Jun;2(3):335-40.

PMID:
1627869
16.

Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing.

Sutanto-Ward E, Sigurdson ER, Tremiterra S, Lincer R, Chapman D, Niedzwiecki D.

Surg Oncol. 1992 Feb;1(1):87-95.

PMID:
1341240

Supplemental Content

Loading ...
Support Center